BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

860 related articles for article (PubMed ID: 31581132)

  • 1. CircRNA Cdr1as functions as a competitive endogenous RNA to promote hepatocellular carcinoma progression.
    Su Y; Lv X; Yin W; Zhou L; Hu Y; Zhou A; Qi F
    Aging (Albany NY); 2019 Oct; 11(19):8183-8203. PubMed ID: 31581132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CircRNA-104718 acts as competing endogenous RNA and promotes hepatocellular carcinoma progression through microRNA-218-5p/TXNDC5 signaling pathway.
    Yu J; Yang M; Zhou B; Luo J; Zhang Z; Zhang W; Yan Z
    Clin Sci (Lond); 2019 Jul; 133(13):1487-1503. PubMed ID: 31278132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative Proteomics Reveals the Regulatory Networks of Circular RNA CDR1as in Hepatocellular Carcinoma Cells.
    Yang X; Xiong Q; Wu Y; Li S; Ge F
    J Proteome Res; 2017 Oct; 16(10):3891-3902. PubMed ID: 28892615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. hsa_circ_0091570 acts as a ceRNA to suppress hepatocellular cancer progression by sponging hsa-miR-1307.
    Wang YG; Wang T; Ding M; Xiang SH; Shi M; Zhai B
    Cancer Lett; 2019 Sep; 460():128-138. PubMed ID: 31207319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circular RNA Circ100084 functions as sponge of miR‑23a‑5p to regulate IGF2 expression in hepatocellular carcinoma.
    Yang J; Li Y; Yu Z; Zhou Y; Tu J; Lou J; Wang Y
    Mol Med Rep; 2020 Jun; 21(6):2395-2404. PubMed ID: 32323783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. circFBLIM1 act as a ceRNA to promote hepatocellular cancer progression by sponging miR-346.
    Bai N; Peng E; Qiu X; Lyu N; Zhang Z; Tao Y; Li X; Wang Z
    J Exp Clin Cancer Res; 2018 Jul; 37(1):172. PubMed ID: 30053867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CircRNA-5692 inhibits the progression of hepatocellular carcinoma by sponging miR-328-5p to enhance DAB2IP expression.
    Liu Z; Yu Y; Huang Z; Kong Y; Hu X; Xiao W; Quan J; Fan X
    Cell Death Dis; 2019 Nov; 10(12):900. PubMed ID: 31776329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hsa-circRNA-103809 Promotes Hepatocellular Carcinoma Development via MicroRNA-1270/PLAG1 Like Zinc Finger 2 Axis.
    Cao Y; Tao Q; Kao X; Zhu X
    Dig Dis Sci; 2021 May; 66(5):1524-1532. PubMed ID: 32683589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Circular RNA Cdr1as Act as an Oncogene in Hepatocellular Carcinoma through Targeting miR-7 Expression.
    Yu L; Gong X; Sun L; Zhou Q; Lu B; Zhu L
    PLoS One; 2016; 11(7):e0158347. PubMed ID: 27391479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA SBF2-AS1 promotes hepatocellular carcinoma progression through regulation of miR-140-5p-TGFBR1 pathway.
    Li Y; Liu G; Li X; Dong H; Xiao W; Lu S
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2826-2832. PubMed ID: 30115383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CircRNA circ-0038718 promotes hepatocellular carcinoma progression through sponging miR-139-3p.
    Sun R; Li H; Li J; Shen S; Cui G; Dong G
    Biochem Biophys Res Commun; 2020 Dec; 533(4):845-852. PubMed ID: 33008587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circular RNA hsa_circ_103809 suppresses hepatocellular carcinoma proliferation and invasion by sponging miR-620.
    Li X; Shen M
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(2):555-566. PubMed ID: 30720163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The circular RNA ciRS-7 (Cdr1as) acts as a risk factor of hepatic microvascular invasion in hepatocellular carcinoma.
    Xu L; Zhang M; Zheng X; Yi P; Lan C; Xu M
    J Cancer Res Clin Oncol; 2017 Jan; 143(1):17-27. PubMed ID: 27614453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circular RNA cSMARCA5 inhibits growth and metastasis in hepatocellular carcinoma.
    Yu J; Xu QG; Wang ZG; Yang Y; Zhang L; Ma JZ; Sun SH; Yang F; Zhou WP
    J Hepatol; 2018 Jun; 68(6):1214-1227. PubMed ID: 29378234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. circ-BIRC6, a circular RNA, promotes hepatocellular carcinoma progression by targeting the miR-3918/Bcl2 axis.
    Yang G; Wang X; Liu B; Lu Z; Xu Z; Xiu P; Liu Z; Li J
    Cell Cycle; 2019 May; 18(9):976-989. PubMed ID: 30931701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CircRNA-Cdr1as Exerts Anti-Oncogenic Functions in Bladder Cancer by Sponging MicroRNA-135a.
    Li P; Yang X; Yuan W; Yang C; Zhang X; Han J; Wang J; Deng X; Yang H; Li P; Tao J; Lu Q; Gu M
    Cell Physiol Biochem; 2018; 46(4):1606-1616. PubMed ID: 29694981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosomal circRNA-100338 promotes hepatocellular carcinoma metastasis via enhancing invasiveness and angiogenesis.
    Huang XY; Huang ZL; Huang J; Xu B; Huang XY; Xu YH; Zhou J; Tang ZY
    J Exp Clin Cancer Res; 2020 Jan; 39(1):20. PubMed ID: 31973767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NUDT21 regulates circRNA cyclization and ceRNA crosstalk in hepatocellular carcinoma.
    Li X; Ding J; Wang X; Cheng Z; Zhu Q
    Oncogene; 2020 Jan; 39(4):891-904. PubMed ID: 31570791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circular RNA profiling identifies circADAMTS13 as a miR-484 sponge which suppresses cell proliferation in hepatocellular carcinoma.
    Qiu L; Huang Y; Li Z; Dong X; Chen G; Xu H; Zeng Y; Cai Z; Liu X; Liu J
    Mol Oncol; 2019 Feb; 13(2):441-455. PubMed ID: 30537115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CDR1as/miRNAs-related regulatory mechanisms in muscle development and diseases.
    Kyei B; Li L; Yang L; Zhan S; Zhang H
    Gene; 2020 Mar; 730():144315. PubMed ID: 31904497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.